Keywords: pulmozyme, cleared, advanced, cf, genentech, recombinant, dnase

Pulmozyme Cleared For Advanced CF

Article | 16 December 1996

Print This

Genentech's recombinant DNase product Pulmozyme (dornase alfa) has now been approved in the USA to treat cystic fibrotics in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in